|
ADAM9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.41000000026304E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.04729999994557E-06 |
| Normal-vs-Stage2 |
1.343540E-02 |
| Normal-vs-Stage3 |
5.284200E-03 |
| Normal-vs-Stage4 |
2.523800E-03 |
| Stage1-vs-Stage2 |
7.661200E-01 |
| Stage1-vs-Stage3 |
9.700800E-01 |
| Stage1-vs-Stage4 |
7.738200E-01 |
| Stage2-vs-Stage3 |
8.324200E-01 |
| Stage2-vs-Stage4 |
6.678800E-01 |
| Stage3-vs-Stage4 |
8.198600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.62920000052114E-07 |
| Normal-vs-AfricanAmerican |
1.556440E-01 |
| Normal-vs-Asian |
2.591700E-02 |
| Caucasian-vs-AfricanAmerican |
1.088100E-02 |
| Caucasian-vs-Asian |
8.503400E-01 |
| AfricanAmerican-vs-Asian |
2.019400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.97620000053878E-07 |
| Normal-vs-Female |
3.393800E-04 |
| Male-vs-Female |
3.096800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.328100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.60156999999828E-05 |
| Normal-vs-Age(61-80Yrs) |
4.40320000000272E-05 |
| Normal-vs-Age(81-100Yrs) |
2.076600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.083800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.420400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.787000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.294200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.198000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.662600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.811200E-04 |
| Normal-vs-Grade 2 |
4.05000000003319E-06 |
| Normal-vs-Grade 3 |
8.18170000000951E-05 |
| Normal-vs-Grade 4 |
2.488100E-02 |
| Grade 1-vs-Grade 2 |
3.435800E-01 |
| Grade 1-vs-Grade 3 |
3.146600E-01 |
| Grade 1-vs-Grade 4 |
1.759220E-01 |
| Grade 2-vs-Grade 3 |
4.192200E-01 |
| Grade 2-vs-Grade 4 |
1.838410E-01 |
| Grade 3-vs-Grade 4 |
4.644400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.44790000000672E-06 |
| Normal-vs-ccB subtype |
6.15539999999637E-05 |
| ccA subtype-vs-ccB subtype |
8.360800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22930000000066E-05 |
| Normal-vs-N1 |
5.916200E-02 |
| N0-vs-N1 |
2.845400E-01 |
|
|
